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Abstract The adult liver-specific IGF-II promoter P1 is 
activated by CCAATfEnhancer Binding Proteins ~ and [~. Here 
we present evidence that promoter P1, in addition to positively 
regulating elements, contains two elements of 67 nucleotides that 
form an inverted repeat (IR) and suppress P1 activity. The two 
IR elements are specifically bound by a protein (inverted repeat 
binding factor, IRBF). The amounts of IRBF in various cell lines 
correlate with the levels of suppression of P1 activity, suggesting 
that this factor is responsible for the suppression of P1 mediated 
by the IR elements. 
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1. Introduction 
Human insulin-like growth factor II ( IGF-I I) is a 67 amino 
acids long protein that influences both proliferation and dif- 
ferentiation in a cell type and development-dependent man- 
ner. Since the functions of IGF- I I  are so diverse, it is not 
surprising that the regulation of IGF- I I  production is very 
complex. At the transcriptional level, regulation takes place 
by differential activation of four distinct promoters (P1-P4) 
which give rise to a family of IGF- I I  encoding mRNAs [1]. 
In fetal liver IGF- I I  transcription is directed by the promoters 
P2, P3, and P4, of which P3 is the most active one. After 
birth, these promoters are down-regulated and promoter P1 
is activated [2]. We have reported previously that an impor- 
tant class of regulators of the adult liver-specific promoter P1 
is the CCAAT/enhancer binding protein (C/EBP) family of 
transcription factors [3,4]. These factors are present at high 
levels in adult liver, whereas fetal liver produces little or no C/ 
EBP factors [5,6]. Furthermore, we found that the distal re- 
gion of P1 exerts a negative effect on P1 promoter activity 
[3,7], indicating that, in addition to positive regulation by C~ 
EBP factors, negative regulation of P1 activity also takes 
place. In the present study we have investigated the putative 
negative regulatory activity present in the distal region of P1. 
Interestingly, the distal region of P1 contains two 67 bp ele- 
ments located at positions -877 to -812  (element IR1) and at 
positions -243 to -177 (element IR2), respectively, which are 
oriented as an inverted repeat. The effect of the IR elements 
on P1 activity has been examined and a putative role for the 
IR elements in tissue-specific expression is discussed. 
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2. Materials and methods 
2.1. Plasmid construction 
The luciferase reporter gene construct containing the TK promoter 
(TK-Luc) and the Pl-luciferase constructs SN-Luc, BsN-Luc, and 
PsN-Luc containing P1 fragments ending at position +54 and begin- 
ning at positions -892, -342, and -207, respectively, have been 
described [4,7]. Mutant Pl-luciferase construct dBP-Luc in which 
the fragment from positions -337 to -208 is deleted, was constructed 
by inserting a SmaI-BstEII P1 fragment (positions -892 to -338), 
which was made blunt using Klenow polymerase, in front of the -207 
to +54 P1 fragment in PsN-Luc, of which the PstI site was made blunt 
using T4 polymerase. Several P1 fragments were cloned in front of the 
TK promoter in TK-Luc. Construct SP-TK-Luc contains the Sinai 
Pvull fragment of P1 (positions -892 to -163) cloned into the PvulI 
site in front of the TK promoter. Construct PS-TK-Luc contains the 
same SmaI-PvulI fragment in an inverted orientation. Similarly, con- 
structs SB-TK-Luc and BS-TK-Luc contain the SmaI-BstEII P1 frag- 
ment (positions -892 to -338) in two orientations, and constructs 
BP-TK-Luc and PB-TK-Luc contain the BstEII-PvulI PI fragment 
(positions 342 to -163) in two orientations. Constructs BP2-TK- 
Luc and PB2-TK-Luc contain two tandemly arranged BstElI-PvulI 
P1 fragments in two orientations. The PI subclone pNc]3 contains the 
Ncil P1 fragment from positions -893 to -685, which was filled in 
using Klenow polymerase and cloned into the Sinai site of pUC18. 
The expression vector for C/EBPc~, CMV-C/EBPa. has been described 
[81. 
2.2. Transient ransfection assays 
Hep3B [9] and PLC/PRF/5 [10] cells were cultured in a-modified 
Minimum Essential Medium, and IN157 cells [11] were cultured in 
Dulbecco's Modified Eagles Medium. Media were supplemented with 
10% fetal calf serum, 100 lag/ml streptomycin, 100 IU/ml penicillin, 
and 300 lag/ml glutamine. Cells were grown in 25-cm 2 flasks to 50- 
70% confluence and transfected using a modified calcium-phosphate 
precipitation protocol [12]. Each flask was transfected with 2 lag of 
luciferase construct, 0.5 lag of expression vector, and 0.25 lag of 
pRSV-LacZ, which served as an internal control for transfection effi- 
ciency. The amount of DNA was kept constant by the addition of 
carrier DNA up to 10 lag of DNA per flask. Preparation of cell 
extracts, ~-galactosidase assays, and luciferase assays were performed 
as described [12,13]. Luciferase values obtained with Pl-luciferase 
constructs were approx. 100-fold higher than background values ob- 
tained with a promoterless luciferase vector, and 5- to 10-fold lower 
than values obtained with TK-Luc. Each transfection presented in this 
report was performed with duplicate samples and has been repeated at 
least three times using different batches of plasmid DNA. 
2.3. Electrophoretic mobility shift assays 
The P1 fragment containing the upstream IRI elements was iso- 
lated from pNci3 by digestion with BamHI and EcoRI and radioac- 
tively labelled using Klenow polymerase and [c~-32p]dATP. A frag- 
ment containing IR2 was obtained by isolating the BstEII-PvulI 
fragment from BsN-Luc and labelled using [ot-32P]dGTP. The follow- 
ing oligonucleotides were synthesized on a Pharmacia/LKB Gene As- 
sembler Plus and purified using a Sephadex G-50 column: 
IR2 upper: 5'-GATCCTGGCTGGGCCTGGGGCTGGCATGG- 
GCTGTGGCTGCAGACCACTGCCAGCTTGGGCCTCGAGGC- 
CAGGT-3' 
IR2 lower: 5'-TCGAACCTGGCCTCGAGGCCCAAGCTGGCA- 
GTGGTCTGCAGCCACAGCCCATGCCAGCCCCAGGCCCAG- 
CCAG-3' 
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Double-stranded ( s) IR2 oligonucleotide was prepared by anneal- 
ing the IR2 upper and lower oligonucleotides, and was purified on a 
non-denaturing 19:1 polyacrylamide gel. The sequence of the ds IR2 
oligonucleotide maps at positions -243 to -177 relative to the tran- 
scription start site in P1. The sequence of the P1 CBS upper and lower 
oligonucleotides have been described [4]. Purified ds oligonucleotide 
was radioactively labelled using [7-32P]ATP and T4-kinase. Protein 
extracts from cell lines were prepared as described [14,15]. EMSA 
reaction mixtures contain 20 mM HEPES-KOH (pH 7.6), 1 mM 
MgCI2, 60 mM KC1, 1 lxg poly(dI.dC), 1 mM DTT, 0.018% NP40, 
and were used as described [7]. Bound and unbound probes were 
separated on a non-denaturing 37.5:1 polyacrylamide gel and visua- 
lised by autoradiography. 
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3. Results 
3.1. The distal region of pl  exerts a negative ffect on 
pl activity 
The negative regulatory activity exerted by the distal region 
of P1 was examined by introduction of long and short P1- 
reporter constructs (Fig. 1A) into the human cell lines Hep3B, 
PLC/PRF/5, and IN157, respectively, which exhibit differen- 
tial IGF- I I  expression. In the hepatoma cell line PLC/PRF/5 
low P1 activity can be detected, whereas P2, P3 and P4 are 
silent [4]. In contrast, the hepatoma cell line Hep3B exhibits 
high endogenous P3 activity and little or no P1 activity [4]. 
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Fig. 1. Schematic representation f IGF-II PI luciferase constructs and their activities. (A) IGF-lI-Pl-luciferase constructs SN-Luc and PsN- 
Luc used in transient transfection experiments. Numbers indicate nucleotide positions relative to the transcription start site (+1). The positions 
of the two IR elements in P1 are -877 to -812 (element IRI) and -243 to -177 (element IR2). (B) Expression of IGF-II-Pl-luciferase gene 
constructs SN-Luc and PsN-Luc transiently transfected into the cell lines Hep3B, IN157, and PLC/PRF/5, respectively. For details of the trans- 
fection assays see Section 2. Activities of the luciferase constructs carrying either a long P1 fragment (SN-Luc, open bars) or a truncated P1 
fragment (PsN-Luc, filled bars) are indicated as % of promoter activity measured for SN-Luc, which was arbitrarily set to 100%. Standard er- 
rors are indicated. All data represent the mean and standard eviation of at least three samples. (C) Expression of IGF-II Pl-luciferase gene 
constructs SN-Luc and PsN-Luc transiently co-transfected into Hep3B and PLC/PRF/5 cells together with an expression vector encoding the 
C/EBPct transcription factor. All reporter gene activities were normalised and expressed as percentage of the promoter activity of SN-Luc which 
value was arbitrarily set to 100%. 
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Fig. 2. Expression of IGF-lI-Pl-TK-luciferase gene constructs transiently transfected into Hep3B cells. For experimental details ee Section 2. 
Constructs carrying PI fragments with the IR elements in various orientations were cloned in front of the TK promoter. All reporter gene ac- 
tivities were normalised and expressed as percentage of the activity of the wild-type TK promoter (TK-Luc) which was arbitrarily set to 100%. 
IN157 is a rhabdomyosarcoma cellline that shows an IGF-I I  
expression pattern very similar to that of Hep3B [11]. Trans- 
fection of Hep3B cells with the P1 PsN-Luc truncated promo- 
ter construct hat contains only 207 bp of P1 coupled to the 
luciferase reporter gene showed a 1.8-fold higher promoter 
activity than a construct containing 892 bp of P1 (SN-Luc) 
(Fig. 1B). This is in agreement with previous observations 
[3,7]. Transfection of IN157 cells with these P1 constructs 
also showed a 2-fold increase in the activity of the PsN-Luc 
construct compared to the SN-Luc construct. In contrast, in 
PLC/PRF/5 cells the activities of the short and long P1 frag- 
ments differ only marginally (Fig. 1B). These results indicate 
that deletion of the P! region between positions -892 and 
-207 removes a region that exerts a negative effect on PI 
activity in Hep3B and IN157 cells. Furthermore, this inhibi- 
tory effect on transcription of the SN-Luc P1 construct is cell 
type-dependent, since PLC/PRF/5 cells do not exhibit such an 
effect. Since the -892 to -207 region contains IR1 and most 
of IR2, two additional deletion mutants of SN-Luc were cre- 
ated to determine whether the IR elements were involved in 
the negative regulatory effect that is exerted by the distal P1 
region in Hep3B and IN157 cells. In construct BsN-Luc the 
region from -892 to -342 containing IR1 was deleted, and in 
construct dBP-Luc the region from -342 to -207 is absent 
(Fig. 1A). In the latter case most of the IR2 element has been 
removed. Hep3B cells were transfected with these two single 
IR-deletion constructs, and the promoter activities of these P1 
constructs were compared to the promoter activities of the 
long SN-Luc construct that contains both IR elements. 
Whereas deletion of both IR elements (PsN-Luc) leads to a 
2-fold activation (Fig. 1B), deletion mutants carrying IR1 
(dBP-Luc) or IR2 (BsN-Luc) show only a 1.2-fold higher 
promoter activity than SN-Luc. Obviously, the presence of a 
single IR element already leads to suppression of P1 activity. 
Transfection experiments have shown that high P1 activity 
(10- to 15-fold induction) can be obtained in hepatoma cells 
when the cells are co-transfected with expression vectors en- 
coding the C/EBP transcription factors C/EBPct or C/EBP[~ 
[4]. We tested whether IR-mediated suppression of P1 could 
still occur when P1 activity is highly stimulated by C/EBPct. 
Hep3B and PLC/PRF/5 cells were transiently co-transfected 
with either SN-Luc or PsN-Luc, together with an expression 
vector encoding the liver-enriched transcription factor C/ 
EBPct (Fig. 1C), In PLC/PRF/5 cells no PI suppression is 
observed in the presence of C/EBPct, which is similar to the 
results obtained in PLC/PRF/5 cells in the absence of C/EBPct 
(Fig. I B). In Hep3B cells co-transfected with a C/EBPct ex- 
pression plasmid, suppression of transcription of the SN-Luc 
construct was again observed (Fig. 1C). This shows that C/ 
EBPct does not interfere with the IR-effect, and that IR- 
mediated suppression of P1 occurs even when P1 activity is 
highly stimulated by C/EBP transcription factors. 
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3.2. The negative ffect on transcription of the distal P1 region 
can be transferred to the thymidine kinase promoter 
In general, enhancer and suppressor elements act relatively 
independent of their orientation and position. Furthermore, 
the effects that these elements exert on transcription are often 
transferable to heterologous promoters. To further examine 
the effect of the IR elements on transcription, we tested 
whether the negative ffect exerted by the PI distal region 
could be transferred to a heterologous promoter. Therefore, 
the distal P1 region (positions -892 to -162) containing both 
IR elements was coupled in two orientations to the thymidine 
kinase (TK) promoter fused to the luciferase reporter gene 
(SP-TK-Luc and PS-TK-Luc, Fig. 2). Transfection of 
Hep3B cells with these hybrid promoter constructs containing 
the IR elements showed a 40% reduction in promoter activity 
as compared to the wild-type TK promoter activity (Fig. 2). 
This level of suppression of TK promoter activity is compar- 
able to the level of suppression of IGF-II promoter P1 con- 
taining the IR elements in their natural context. Transfection 
of various hybrid TK constructs containing PI fragments in 
which either IR1 or IR2 was present still showed a 3040% 
suppression of TK promoter activity, irrespective of the or- 
ientation of the fragments. Thus, also in front of the hetero- 
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Fig. 3. Formation of DNA-protein complexes with probes contain- 
ing the IR elements and Hep3B nuclear extracts. EMSA of end-la- 
belled IR eler~-ent containing probes with 2.5 lag of Hep3B nuclear 
extract. The 176 bp long IR2 probe contains P1 sequences from po- 
sitions -338 to -163, and the 209 bp IRl-probe contains PI se- 
quences from positions -893 to -685. Competition analyses for 
binding were performed by addition of a 50-fold molar excess of 
unlabelled s oligonucleotides containing the IR2 element (positions 
-243 to -177) or a non-specific oligonucleotide (P1 CBS) repre- 
senting P1 at positions -110 to -87. Non-bound probe is indicated 
(FP). 
FP 
Fig. 4. Formation of protein-DNA complex with the IR2 element 
and nuclear extracts of various cell lines. EMSA of end-labelled ds
oligonucleotide fragment (positions -243 to -177), representing the 
IR2 element. 5 I.tg of nuclear extract from the PLC/PRF/5, Hep3B, 
and IN157 cell lines, respectively, were incubated with excess la- 
belled probe. Non-bound probe is indicated (FP). 
logous TK promoter the presence of IR elements gives rise to 
suppression of promoter activity, which is similar to the re- 
sults obtained with the IGF-II P1 promoter constructs. 
3.3. Elements IR1 and IR2 can be bound by a specific protein 
The mechanism by which enhancer and silencer elements 
usually influence transcription is by recruiting factors that 
specifically bind to these elements, and exert their effect on 
basal transcription. To test whether proteins can bind to the 
IR elements, an Electrophoretic Mobility Shift Assay (EMSA) 
was performed using radioactively abelled P1 fragments car- 
rying either the IR1 element or the IR2 element. Incubation of 
the two IR element containing probes with Hep3B nuclear 
extract resulted for each of the DNA probes in the formation 
of one major protein-DNA complex and two minor more 
slowly migrating complexes (Fig. 3). These complexes were 
efficiently competed away after addition of an unlabelled 67 
bp ds oligonucleotide carrying only the IR2 basepair se- 
quence. This demonstrates that the IR element present in 
each probe is responsible for the protein-DNA complexes 
that are formed with Hep3B nuclear extract and IR contain- 
ing fragments. Addition of an unlabelled non-specific ds oli- 
gonucleotide (P1 CBS) does not influence binding of Hep3B 
protein to the IR elements, which shows that binding to the 
IR elements i specific (Fig. 3). The major protein that binds 
to the IR elements will be referred to as inverted repeat bind- 
ing factor (IRBF). 
In order to optimise conditions for IRBF binding, the ef- 
fects of varying salt and EDTA conditions were tested. It was 
found that 1RBF binding is lost at KC1 concentrations of 300 
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mM and higher, therefore 60 mM of KC1 was used in further 
IRBF binding studies. Addition of 1 mM of EDTA to the 
binding reaction mixture already inhibits IRBF binding, 
which shows that IRBF binding is depending on divalent ca- 
tions (results not shown). 
3.4. The levels of lRBF correlate with the levels of suppression 
of transcription of PI 
The level of suppression of transcription of P1 was found to 
vary among different cell lines; in Hep3B and IN157 cells 
promoter activity is inhibited to approx. 50%, whereas in 
PLC/PRF/5 cells hardly any inhibition can be observed. Since 
the IR elements that are involved in PI suppression were 
found to be specifically bound by IRBF protein, the question 
arises whether there is a correlation between the level of sup- 
pression and the amount of IRBF in these cell lines. There- 
fore, EMSA experiments were performed using the ds IR2 
oligonucleotide as a probe and nuclear extracts prepared 
from the cell lines PLC/PRF/5, Hep3B, and IN157, respec- 
tively. In these EMSA experiments a large excess of probe 
was used to ensure that all IRBF present in the nuclear ex- 
tracts could bind to the probe. It was found that the amount 
of IRBF in PLC/PRF/5 nuclear extract is much lower than 
the IRBF levels in Hep3B and IN157 nuclear extracts (Fig. 4). 
This differential expression of IRBF correlates very well with 
the relative levels of suppression of P1 activity in these cell 
lines (Fig. 1B) and suggests that binding of IRBF to the IR 
elements i  responsible for the inhibition of promoter activity. 
The level of P1 suppression is therefore primarily determined 
by the amount of IRBF that can bind to the IR elements. 
4. Discussion 
The proximal region of the liver-specific IGF-I I  promoter l 
contains two 67 bp regions, which are orientated as an in- 
verted repeat (IR) spaced by 568 bp. In this report we present 
evidence that these two IR elements act as cell type-specific 
negative regulators of P1 activity. Analysis of the promoter 
activity of P1 constructs carrying deletions of one or both IR 
elements by transient transfection of Hep3B cells demon- 
strates that the presence of the IR elements leads to approxi- 
mately 45% suppression of Pl promoter activity. The suppres- 
sing effect of the IR elements could be transferred to the 
Thymidine Kinase promoter, resulting in a 35%-50% reduc- 
tion in promoter activity compared to wild-type TK promoter 
activity, irrespective of the relative orientation and spacing of 
the IR elements. 
Incubation of either IR element with Hep3B nuclear extract 
results in the formation of a major protein-DNA complex, 
which is caused by binding of the IRBF. The level of IRBF 
varies among different cell lines; Hep3B and IN157 cells con- 
tain large amounts of IRBF, whereas PLC/PRF/5 cells express 
low levels of IRBF, which shows that the level of IRBF ex- 
pression is cell type-dependent. The amounts of IRBF that are 
present in extracts prepared from Hep3B, IN157, and PLC/ 
PRF/5, correlate with the levels of suppression of P1 activity 
mediated by the IR elements in these cell lines. In the cell lines 
Hep3B and IN157, the IR elements uppress P1 activity up to 
50%. However, in the cell line PLC/PRF/5 only 10% suppres- 
sion is observed. These observations suggest hat the level of 
IRBF determines the level of IR-mediated suppression of P1 
promoter activity. 
In several hepatoma cell lines that we have tested for IGF- 
II expression, activity of P1 is either completely lost or re- 
duced to a low level [4]. In many hepatoma cell lines such 
as Hep3B, the fetal IGF-I I  promoters have been reactivated. 
Low P1 activity in hepatoma cell lines is most likely caused by 
down-regulation of C/EBP transcription factors, a phenomen- 
on that has been observed in proliferating liver cells such as 
hepatoma cells, in vitro cultured primary hepatocytes and re- 
generating liver cells [16,17]. In co-transfection experiments of
hepatoma cells, the levels of P1 activity can be enhanced by 
the addition of exogenous C/EBP~, which is due to a strong 
C/EBP binding site in the proximal region of P1. Although C/ 
EBPct enhances the promoter activity up to 10-fold, the addi- 
tion of C/EBPc~ does not interfere with cell type-dependent 
IR-mediated suppression of P1 activity. 
Hep3B and IN157 exhibit very high endogenous activity of 
the fetal IGF-I I  promoter P3 and little or no P1 activity, 
whereas in PLC/PRF/5 promoter P1 is exclusively active, al- 
beit at a low level [4,11]. Although only a limited number of 
cell lines was tested in this study, it suggests that cell type- 
dependent IR-mediated suppression of P1 is operational in 
cells exhibiting an IGF-I I  expression pattern similar to fetal 
liver. The results presented in the present report support he 
notion that the activity of the liver-specific IGF-I I  promoter 
P1 is regulated by an interplay of positive and negative reg- 
ulatory proteins. 
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